Antiviral effects of Lactobacillus ruminis SPM0211 and Bifidobacterium longum SPM1205 and SPM1206 on rotavirus-infected Caco-2 cells and a neonatal mouse model.
Rotavirus is worldwide cause of severe gastroenteritis including severe diarrhea and fatal dehydration in infants and young children. There is an available vaccination program for preventing rotavirus infection, but it has limits and restrictions. Probiotics therapy could be an alternative method of antiviral prevention and modulation against rotavirus infection. In this study, we screened the antiviral activity of probiotic bacteria such as 3 Lactobacillus spp. and 14 Bifidobacterium spp. isolated from young Korean. Three of the bacteria, Lactobacillus ruminis SPM0211, Bifidobacterium longum SPM1205, and SPM1206, inhibited human strain Wa rotavirus infection in Caco-2 cells. Furthermore, these bacterial strains inhibited rotavirus replication in a rotavirus-infected neonatal mouse model. To clarify the mechanism of inhibition, we investigated gene expression of Interferon (IFN)-signaling components and IFN-inducible antiviral effectors. All 3 probiotics increased IFN-α and IFN-β levels compared with the control. Gene expression of IFNsignaling components and IFN-inducible antiviral effectors also increased. Overall, these results indicate that L. ruminis SPM0211, B. longum SPM1205 and 1206 efficiently inhibit rotavirus replication in vitro and in vivo. Especially, the antiviral effect of Lactobacillus ruminis SPM0211 is worthy of notice. This is the first report of L. ruminis with antiviral activity. Anti-rotaviral effects of the 3 probiotics are likely due to their modulation of the immune response through promoting type I IFNs, which are key regulators in IFN signaling pathway.
College of Pharmacy, Duksung Women's University, Seoul, 01369, Republic of Korea.
Joo Yeon
JY
Kang
College of Pharmacy, Sahmyook University, Seoul, 01795, Republic of Korea.
Do Kyung
DK
Lee
College of Pharmacy, Sahmyook University, Seoul, 01795, Republic of Korea.
Nam Joo
NJ
Ha
College of Pharmacy, Duksung Women's University, Seoul, 01369, Republic of Korea. hsshin@duksung.ac.kr.
Hea Soon
HS
Shin
D000818:Animals; D000831:Animals, Newborn; D000898:Antibiosis; D001644:Bifidobacterium / Q000302:isolation & purification / Q000502:physiology*; D018938:Caco-2 Cells; D004195:Disease Models, Animal; D006801:Humans; D016898:Interferon-alpha / Q000235:genetics; D016899:Interferon-beta / Q000235:genetics; D007778:Lactobacillus / Q000302:isolation & purification / Q000502:physiology*; D051379:Mice; D019936:Probiotics / Q000627:therapeutic use*; D060888:Real-Time Polymerase Chain Reaction; D012401:Rotavirus / Q000502:physiology*; D012400:Rotavirus Infections / Q000628:therapy* / Q000821:virology*; D014779:Virus Replication
D016898:Interferon-alpha; D016899:Interferon-beta
Bifidobacterium longum; Lactobacillus ruminis; antiviral effects; probiotics; rotavirus